Skip to content

Advertisement

  • Research
  • Open Access

Comparative analyses of DHA-Phosphatidylcholine and recombination of DHA-Triglyceride with Egg-Phosphatidylcholine or Glycerylphosphorylcholine on DHA repletion in n-3 deficient mice

Lipids in Health and Disease201716:234

https://doi.org/10.1186/s12944-017-0623-2

  • Received: 14 November 2017
  • Accepted: 26 November 2017
  • Published:

Abstract

Background

Docosahexaenoic acid (DHA) is important for optimal neurodevelopment and brain function during the childhood when the brain is still under development.

Methods

The effects of DHA-Phosphatidylcholine (DHA-PC) and the recombination of DHA-Triglyceride with egg PC (DHA-TG + PC) or α-Glycerylphosphorylcholine (DHA-TG + α-GPC) were comparatively analyzed on DHA recovery and the DHA accumulation kinetics in tissues including cerebral cortex, erythrocyte, liver, and testis were evaluated in the weaning n-3 deficient mice.

Results

The concentration of DHA in weaning n-3 deficient mice could be recovered rapidly by dietary DHA supplementation, in which DHA-PC exhibited the better efficacy than the recombination of DHA-Triglyceride with egg PC or α-GPC. Interestingly, DHA-TG + α-GPC exhibited the greater effect on DHA accumulation than DHA-TG + PC in cerebral cortex and erythrocyte (p < 0.05), which was similar to DHA-PC. Meanwhile, DHA-TG + PC showed a similar effect to DHA-PC on DHA repletion in testis, which was better than that of DHA-TG + α-GPC (p < 0.05).

Conclusion

We concluded that different forms of DHA supplements could be applied targetedly based on the DHA recovery in different tissues, although the supplemental effects of the recombination of DHA-Triglyceride with egg PC or α-GPC were not completely equivalent to that of DHA-PC, which could provide some references to develop functional foods to support brain development and function.

Keywords

  • DHA-Phosphatidylcholine
  • Tissue accretion kinetics
  • Repletion
  • N-3 Fatty acid deficiency
  • Weaning

Background

Docosahexaenoic acid (DHA) is highly accumulated in the brain and retina, which is critical for normal nervous development and function [1, 2]. Docosahexaenoic acid can be synthesized from its essential fatty acid precursor, α-linolenic acid (ALA). However, the capacity of brain for synthesizing the long-chain polyunsaturated fatty acids is very limited especially in early life stage, thus DHA is mainly supplied via the uteroplacental circulation during pregnancy and the breast milk during nursing [3]. Many pregnant women cannot intake sufficient n-3 polyunsaturated fatty acids (PUFAs) during pregnancy and lactation in modern western diets, which is likely responsible for the DHA deficiency in developing brains of infants and the increasing incidence of neurological disorders [4, 5]. There have been many nutritional means such as the dietary supplements of ALA and DHA to promote the recovery of organ DHA during the timeframe of gestation and/or lactation [6, 7]. Moreover, particular aspects of neurodevelopment such as synaptic pruning and gliogenesis still continue in childhood, suggesting that the nutrition on brain function is critical during this period [8]. Previous studies showed that direct DHA supplements could increase dendritic spine density and neuritogenesis in the hippocampus of mouse [9]. However, to the best of our knowledge, very few studies have investigated the DHA accumulation kinetics in the brain and other tissues during the childhood.

DHA in natural fish oil is normally esterified to triglyceride (TG) and phospholipid (PL). DHA enriched phosphatidylcholine (DHA-PC) is one of the important forms in DHA-PLs. Several studies have shown that DHA-PC exhibited the higher bioavailability and more effective accumulation in brain compared with DHA-TG [10, 11]. Moreover, dietary ingestion of DHA-PC produced a more significant improvement in cognitive performance and emotional well-being than DHA-TG [9]. This might be attributed to its special molecular form including both DHA and phosphatidylcholine (PC). However, the source of DHA-PC is relatively limited compared to DHA-TG, so we expected that whether recombination of DHA-TG with normal PC (not containing any DHA) could be a substitution of DHA-PC on DHA accumulation in tissues. Interestingly, DHA-PC containing one molar of DHA (sn-2) and one molar of PC could be hydrolyzed into sn-2-lysoPC and free DHA by pancreatic phospholipase A2 in intestine. In addition, triglyceride enriched with high levels of DHA was predominantly hydrolyzed into sn-2-monoacylglycerol and free DHA, and ordinary PC was hydrolyzed to sn-2-lysoPC in the intestinal lumen [12].When re-esterification of absorbed fatty acids in erythrocyte was governed by pure availability of compounds, we expected that the recombination of DHA-TG and ordinary PL (not containing any DHA) could have the same effect as intaking DHA-PC on DHA supplementation. Egg PC is an economical and widely applied functional food supplement, which is rich in saturated fatty acids and monounsaturated fatty acids. α-glycerylphosphorylcholine (α-GPC) is water soluble for its special chemical form with one molecule of choline. The different chemical structure of PC might influence the DHA supplement.

Therefore, the present work was investigated to comparatively analyze the effects of DHA- PC and recombination of DHA-TG with egg PC or α-GPC on DHA repletion by weaning n-3 deficient mice model. The results of this study could provide a meaningful reference to improve n-3 PUFAs deficiency by dietary DHA supplement during childhood.

Methods

Preparation of DHA-TG and DHA-PC

DHA-PC was separated following the methods as previously performed [13]. Briefly, total lipids were extracted from squid roe (S. oualaniensis) and then mixed with one-fifth volume of 0.15 M NaCl solution. The mixture was placed into a separatory funnel and kept for 24 h to completely clear the bottom (chloroform) phase. The chloroform solution was evaporated to dryness under vacuum. Then phospholipids were separated from neutral lipids and glycolipids by silica-gel column chromatography using sequentially chloroform, acetone, and methanol as eluents. The methanol eluent was collected and DHA-PC was obtained after removal of organic solvent under vacuum. The purity of DHA-PC was confirmed according to the HPLC-ELSD analysis (purity >90%). The fatty acid (FA) composition of the DHA-TG, DHA-PC and egg PC was given in Table 1. Dietary α-GPC (purity >99%), egg PC (purity >95%) and DHA-TG were obtained from Tianjin Bodi Chemical Co., Ltd. (Tianjin, China), Suzhou Fushilai Pharmaceutical Co., Ltd. (Suzhou, China) and Weihai Boow Foods Co., Ltd. (Weihai, China), respectively.
Table 1

Fatty acid composition of DHA-TG, DHA-PC and egg-PC

Main fatty acids (%)

DHA-TG

DHA-PC

Egg PC

16:0

0.59

17.51

36.2

18:0

0.34

9.09

12.5

18:1n-9

0.25

8.15

28.9

18:2n-6

0.68

0.28

16.1

18:3n-3

0.42

0.24

0.16

20:1n-9

0.27

9.68

0.18

20:4n-6

0.43

2.78

4.3

20:5n-3

7.82

8.94

nd

22:6n-3

72.56

39.89

0.7

SFAs

12.43

27.77

48.95

MUFAs

5.34

18.82

29.37

N6

1.65

4.28

20.72

N3

80.58

49.13

0.96

nd: trace (< 0.05% of fatty acids)

SFA saturated fatty acid, MUFA monounsaturated fatty acid, PUFA polyunsaturated fatty acid, N-6 n-6 polyunsaturated fatty acids, N-3 n-3 polyunsaturated fatty acids

Animals and diets

All aspects of the animal experiment were carried out in Food Science and Human Health Laboratory of Ocean University of China (Qingdao, P. R. China) and conducted according to guidelines provided by the Ethical Committee of the University (Approval No.: SPXY2015012). The study design was depicted in Fig. 1. Female ICR strain mice aged 7 weeks were purchased from Vital River (Beijing, China) on the second day after conception and immediately randomized into n-3 adequate or n-3 deficient groups, which were fed with n-3 adequate or n-3 deficient diets during pregnancy, respectively. On the first postnatal day, pups were adjusted to 8 per dam and the dams were continually fed with their assigned diets during lactation. All pups were weaned on the 21st postnatal day. The n-3 deficient pups were randomly assigned to four groups as follows: n-3 deficient (n-3 Def) group fed with n-3 deficient diet; DHA-PC group fed with n-3 deficient diet including DHA-PC; DHA-TG + PC group fed with n-3 deficient diet including DHA-TG and egg PC; DHA-TG + α-GPC group fed with n-3 deficient diet including DHA-TG and α-GPC. In addition, the n-3 adequate pups fed with n-3 adequate diet were served as the reference point. The mice were maintained in individual cages under a 12-h light/dark cycle at 23 °C with a 60 ± 10% relative humidity and provided with food and water ad libitum. The basal diets were prepared according to the AIN-93G growth diet and the fatty acid concentration of all diets were summarized in Table 2. The DHA-supplemented diets comprised equal content of DHA + EPA at a dose of 5% of total fatty acid. And the content of PC was adjusted to equimolar ratio of DHA to PC in different DHA-containing diets. The diets were stored at −20 °C and fresh supplies were given to the mice every day. Mice were sacrificed by decapitation after 12-h fast either at weaning or after 2, 4, 7 and 14 days postweaning.
Fig. 1
Fig. 1

Flow schematic depiction of study design. The dams were sacrificed by decapitation and tissues were collected at days 0, 2, 4, 7, 14 after weaning for fatty acid composition analysis by gas chromatography

Table 2

Ingredient and fatty acid compositions of experimental diets

 

Amount (g/100 g diet)

n-3 Adq

n-3 Def

DHA-PC

DHA-TG + PC

DHA-TG + α-GPC

Casein, vitamin free

20

20

20

20

20

Sucrose

10

10

10

10

10

Cornstarch

39.749

39.749

39.749

39.749

39.749

Maltose-dextrin

13.2

13.2

13.2

13.2

13.2

Cellulose

5

5

5

5

5

Mineral-salt mix

3.5

3.5

3.5

3.5

3.5

Vitamin mix

1

1

1

1

1

L-Cystine

0.3

0.3

0.3

0.3

0.3

Choline bitartrate

0.25

0.25

0.25

0.25

0.25

TBHQ

0.002

0.002

0.002

0.002

0.002

Fat

 Hydrogenated coconut oil

5.33

5.59

4.22

3.88

4.56

 Safflower oil

1.33

1.41

1.41

1.41

1.41

 Flaxseed oil

0.34

0

0

0

0

 DHA-PC

0

0

1.37

0

0

 DHA-TG

0

0

0

0.63

0.63

 Egg-PC

0

0

0

1.08

0

 α-GPC

0

0

0

0

0.40

Fatty acid composition (%)

 SFAs

73.01

79.79

71.33

70.1

72.7

 MUFAs

3.94

3.36

5.61

4.65

4.77

 18:2n-6

15.16

14.83

14.51

14.45

14.69

 18:3n-3

2.97

0.08

0.1

0.13

0.16

 20:4n-6

nd

nd

nd

nd

nd

 20:5n-3

nd

nd

1.58

0.43

0.54

 22:6n-3

nd

nd

4.18

5.31

5.16

 N-6/ N-3

5.10

185.38

2.52

2.52

2.58

nd: trace (< 0.05% of fatty acids)

TBHQ tertiary butylhydroquinone, SFA saturated fatty acid, MUFA monounsaturated fatty acid, PUFA polyunsaturated fatty acid, N-6 n-6 polyunsaturated fatty acids, N-3 n-3 polyunsaturated fatty acids

Erythrocytes were obtained from trunk blood by centrifugation and washed with phosphate-buffered saline. The cerebral cortex was separated from the whole brain on ice and weighed. The liver and testis from each pup were dissected out and weighed immediately before snap frozen in liquid nitrogen and then stored at −80 °C until further use. Body weights and food intake were recorded every day throughout the experimental period.

Fatty acid analysis

Total lipids were extracted from samples with a mixture of pentadecanoic acid (15:0) as an internal standard according to the Folch method [14]. The samples with internal standard were extracted by chloroform/methanol (2:1, v/v). The lipid extract was evaporated to dryness under nitrogen flux for analysis of fatty acid composition. The total lipids from liver were separated by thin layer chromatography with a mobile phase of petroleum ether: diethyl ether: acetic acid (82:18:1, v/v/v) as previous study [15]. The hepatic phospholipids and triglycerides were scraped off the plate and the obtained lipids were transmethylated to fatty acid methyl esters (FAMEs) with HCl/methanol by shaking at 90 °C for 3 h. The derivatives were extracted by hexane for fatty acids analysis using standard mixture containing 28 kinds of components to identify the retention times. FAMEs were analyzed by an Agilent 6890 gas chromatograph equipped with aflame-ionization detector and an HPINNOW-AX capillary column (30 m × 0.32 mm × 0.25 μm). The detector and injector temperatures were kept at 250 °C and 240 °C, respectively. The oven temperature was increased from 170 °C to 240 °C at 3 °C/min and then held at 240 °C for 15 min. Nitrogen was used as the carrier gas at the flow rate of 1.2 mL/min.

Statistical analysis

Data were expressed as the mean ± the standard error of the mean (SEM). All the statistical tests were performed with SPSS 18.0 and Figures were made by Graphpad Prism 13.0. Student’s t test was used to compare means between n-3 Def and n-3 Adq groups at 3 weeks of age. Differences between all dietary groups after 3 weeks of age were analyzed by one-way ANOVA. The difference was considered statistically significant when p < 0.05.

Results and discussion

Time course of fatty acids alteration in cerebral cortex

Previous clinical and preclinical studies suggested that the early postnatal period was a critical interval when insufficient ingestion of n-3 PUFAs might be very detrimental [16]. During this period, particular aspects of neurodevelopment were continuing [17] and the impact of lower n-3 PUFA level was correlated with a greater number of further learning and behavior problems [18]. Therefore, a rapid and efficient recovery of DHA in developing brain was important for optimal function, so we studied the DHA accumulation kinetics in weaning n-3 deficient mice supplemented with different forms of DHA.

There were no significant differences observed in food intake, body and tissues weight among all groups during this experiment (data not shown). Interestingly, the initial DHA content in the brain of weaning pups was 14.3% of total fatty acids in n-3 Adq group, but only 7.5% in n-3 Def group, representing a decrease of 47.5% (Fig. 2a; Table 3). As seen in Fig. 2a, the present results also showed a rapid DHA recovery in cerebral cortex, especially the n-3 deficient weaning mice was capable of restoring DHA to the level of the n-3 adequate mice within two weeks by DHA supplementation. All groups including DHA-PC, DHA-TG + PC and DHA-TG + α-GPC exhibited a slight increase of DHA content at 4 post-weaning days but a substantially great amount relative to the n-3 Def group from 4 to 7 days, rising to 12.2, 11.9 and 12.7%, respectively. After 2 weeks, the DHA levels in DHA-PC (16.5%) and DHA-TG + α-GPC (16.1%) groups displayed considerable recovery and nearly reached that of n-3 Adq group (16.2%), which were significantly higher than the DHA-TG + PC group (14.7%). Moreover, the DHA contents of n-3 Def and n-3 Adq groups were only marginally increased within two weeks (n-3 Def group: 7.5–8.1%; n-3 Adq group: 14.3–16.2%). A continually rapid decline in brain DPA was observed in the three DHA-supplemented groups over the subsequent 2 weeks (Fig. 2b; Table 2). The DPA levels of DHA-PC, DHA-TG + PC and DHA-TG + α-GPC groups significantly decreased by 61.3, 62.3 and 57.4% compared to n-3 Def group. The brain DTA and AA patterns for the five dietary groups were quite similar to that of DPA (Fig. 2c and d; Table 3). Compared with n-3 Adq group, the content of DTA and AA in n-3 Def group increased by 55.1 and 14.7% at the weaning day. The AA concentration in the three DHA-containing (DHA-PC, DHA-TG + PC and DHA-TG + α-GPC) mice exhibited a contiguous decline to 9.32, 9.17 and 8.31%, respectively, after DHA supplementation for 4 days. Kitson et al. showed that the DHA content of brain in adult n-3 deficient rat could increase to the normal level after 4 weeks of DHA supplementation [19]. The time courses for the DHA recovery of brain also indicated that the mice required 8 weeks to reach the n-3 adequate level after dietary supplementation of ALA in n-3 deficient mice at 7 weeks of old [20]. Interestingly, the data in present study showed a faster DHA recovery (only 2 weeks required) in the n-3 deficient weaning mice, which was possible that the activity of desaturase enzymes in the young animals was much higher than mature animals [21].
Fig. 2
Fig. 2

Time course curves of DHA (a), DPA (b), AA(c), DTA(d) in cerebral cortex after dietary DHA supplementation from 0 to 14 days. Datas at various time points are given as mean percent ± SEM (n = 5 mice per time point). ** p < 0.01, significant difference compared to the n-3 Adq group at 3 weeks of age determined by Student’s t-test. Different letters indicate significant difference at p < 0.05 among all dietary groups after 3 weeks of age

Table 3

Brain fatty acid composition

Fatty acid (%)

0 day after weaning

4 days after weaning

7 days after weaning

14 days after weaning

n-3 Adq

n-3 Def

n-3 Adq

n-3 Def

DHA-PC

DHA-TG + PC

DHA-TG + α-GPC

n-3 Adq

n-3 Def

DHA-PC

DHA-TG + PC

DHA-TG + α-GPC

n-3 Adq

n-3 Def

DHA-PC

DHA-TG + PC

DHA-TG + α-GPC

14:0

0.55 ± .0.04

0.61 ± 0.04

0.63 ± 0.03

0.65 ± 0.04

0.69 ± 0.03

0.60 ± 0.04

0.61 ± 0.03

0.49 ± 0.01

0.44 ± 0.06

0.45 ± 0.03

0.52 ± 0.03

0.56 ± 0.03

0.70 ± 0.03

0.76 ± 0.02

0.66 ± 0.03

0.66 ± 0.04

0.74 ± 0.05

16:0

22.26 ± 0.27

22.54 ± 0.16

21.23 ± 0.40

21.52 ± 0.30

21.07 ± 0.25

21.48 ± 0.18

21.86 ± 0.17

21.17 ± 0.28

21.09 ± 0.21

20.89 ± 0.17

21.13 ± 0.31

21.54 ± 0.15

20.28 ± 0.31

20.34 ± 0.27

20.41 ± 0.21

20.55 ± 0.23

20.73 ± 0.31

18:0

20.53 ± 0.22

19.95 ± 0.23

19.51 ± 0.31

19.32 ± 0.29

20.06 ± 0.25

19.42 ± 0.25

19.59 ± 0.19

19.38 ± 0.18

19.51 ± 0.21

19.64 ± 0.27

19.84 ± 0.20

19.88 ± 0.23

19.17 ± 0.25

19.35 ± 0.31

19.37 ± 0.22

19.72 ± 0.23

19.61 ± 0.28

SFAs

47.84 ± 0.46

47.42 ± 0.36

47.63 ± 0.36

47.48 ± 0.47

48.14 ± 0.40

47.57 ± 0.54

47.35 ± 0.36

46.55 ± 0.44

46.34 ± 0.33

46.69 ± 0.25

46.13 ± 0.27

45.84 ± 0.39

45.79 ± 0.36

45.92 ± 0.44

45.65 ± 0.25

46.69 ± 0.27

45.69 ± 0.25

16:1n-7

1.32 ± 0.09

1.01 ± 0.12

1.35 ± 0.08

1.21 ± 0.08

1.37 ± 0.09

1.26 ± 0.07

1.37 ± 0.06

1.27 ± 0.03

1.24 ± 0.05

1.44 ± 0.04

1.29 ± 0.10

1.26 ± 0.08

1.38 ± 0.07

1.27 ± 0.05

1.34 ± 0.02

1.34 ± 0.05

1.27 ± 0.01

18:1n-9

14.34 ± 0.24

13.04 ± 0.33

14.96 ± 0.39

14.76 ± 0.27

15.36 ± 0.20

14.75 ± 0.25

14.89 ± 0.23

15.16 ± 0.19

14.98 ± 0.19

15.57 ± 0.28

15.01 ± 0.18

15.08 ± 0.13

15.32 ± 0.32

15.48 ± 0.17

15.96 ± 0.26

15.97 ± 0.18

15.41 ± 0.31

18:1n-7

2.78 ± 0.18

2.89 ± 0.14

2.68 ± 0.15

2.74 ± 0.13

2.69 ± 0.14

2.61 ± 0.11

2.53 ± 0.09

2.55 ± 0.19

2.49 ± 0.16

2.41 ± 0.14

2.82 ± 0.10

2.44 ± 0.14

2.57 ± 0.17

2.35 ± 0.06

2.49 ± 0.11

2.68 ± 0.06

2.53 ± 0.08

MUFAs

22.20 ± 0.47

20.76 ± 0.48

21.86 ± 0.29

21.55 ± 0.33

22.31 ± 0.23

22.51 ± 0.18

22.59 ± 0.22

22.54 ± 0.33

22.86 ± 0.31

22.43 ± 0.27

22.50 ± 0.20

22.58 ± 0.30

22.76 ± 0.30

23.37 ± 0.39

23.07 ± 0.19

23.78 ± 0.27

23.39 ± 0.31

18:2n-6

0.35 ± 0.02

0.46 ± 0.03*

0.42 ± 0.03a

0.54 ± 0.03b

0.61 ± 0.02c

0.58 ± 0.01bc

0.53 ± 0.02b

0.49 ± 0.03

0.52 ± 0.02

0.56 ± 0.03

0.54 ± 0.02

0.51 ± 0.02

0.57 ± 0.02

0.89 ± 0.03

0.42 ± 0.03

0.46 ± 0.02

0.39 ± 0.02

20:4n-6

10.19 ± 0.20

11.97 ± 0.27**

10.20 ± 0.16a

11.72 ± 0.17b

10.34 ± 0.18a

10.17 ± 0.16a

10.14 ± 0.14a

10.04 ± 0.21a

11.70 ± 0.25b

10.01 ± 0.14a

9.96 ± 0.27a

9.97 ± 0.11a

10.35 ± 0.09c

11.45 ± 0.09d

9.32 ± 0.10b

9.17 ± 0.11b

8.81 ± 0.10a

22:4n-6

2.13 ± 0.16

3.32 ± 0.25**

2.22 ± 0.08a

3.12 ± 0.05c

2.80 ± 0.11b

22.92 ± 0.07bc

3.02 ± 0.06bc

2.30 ± 0.11a

3.05 ± 0.12b

2.53 ± 0.24a

2.58 ± 0.07a

2.42 ± 0.09a

2.02 ± 0.08b

3.13 ± 0.07c

1.79 ± 0.06ab

1.86 ± 0.08ab

1.73 ± 0.08a

22:5n-6

1.40 ± 0.15

7.20 ± 0.19**

1.30 ± 0.07a

7.01 ± 0.12d

4.84 ± 0.09b

5.55 ± 0.11c

5.30 ± 0.07c

1.21 ± 0.12a

6.57 ± 0.19c

4.19 ± 0.17b

4.39 ± 0.18b

4.44 ± 0.14b

1.19 ± 0.07a

6.31 ± 0.12c

2.44 ± 0.11b

2.38 ± 0.13b

2.69 ± 0.09b

N-6

15.37 ± 0.25

23.75 ± 0.27**

15.04 ± 0.15a

23.31 ± 0.19c

19.58 ± 0.24b

20.01 ± 0.35b

19.74 ± 0.17b

14.79 ± 0.33a

22.89 ± 0.18d

18.01 ± 0.31b

18.97 ± 0.32bc

18.31 ± 0.21ab

14.63 ± 0.46a

22.77 ± 0.69b

14.05 ± 0.39a

14.31 ± 0.43a

14.17 ± 0.26a

22:6n-3

14.30 ± 0.15

7.50 ± 0.16**

15.01 ± 0.17c

7.60 ± 0.15a

9.31 ± 0.19b

9.50 ± 0.15b

9.82 ± 0.24b

15.54 ± 0.25d

7.79 ± 0.18a

12.21 ± 0.21bc

11.90 ± 0.19b

12.70 ± 0.20c

16.20 ± 0.15c

8.10 ± 0.09a

16.51 ± 0.09c

14.72 ± 0.12b

16.12 ± 0.14c

N-3

14.50 ± 0.23

8.07 ± 0.19**

15.49 ± 0.19c

7.75 ± 0.16a

9.97 ± 0.18b

9.91 ± 0.19b

10.32 ± 0.18b

16.12 ± 0.23d

7.91 ± 0.22a

12.87 ± 0.12bc

12.40 ± 0.23b

13.27 ± 0.15c

16.82 ± 0.15c

8.26 ± 0.12a

17.23 ± 0.13c

15.22 ± 0.14b

16.75 ± 0.19c

PUFAs

29.96 ± 0.63

31.82 ± 0.65

30.51 ± 0.43

31.06 ± 0.51

29.55 ± 0.73

29.92 ± 0.50

30.06 ± 0.39

30.91 ± 0.56

30.80 ± 0.39

30.88 ± 0.43

31.37 ± 0.55

31.58 ± 0.36

31.45 ± 0.47

31.03 ± 0.77

31.28 ± 0.38

29.53 ± 0.45

30.92 ± 0.36

N-6/ N-3

1.06 ± 0.02

2.94 ± 0.04**

0.97 ± 0.01a

3.02 ± 0.07c

1.96 ± 0.04b

2.01 ± 0.03b

1.91 ± 0.04b

0.92 ± 0.01a

2.89 ± 0.07d

1.40 ± 0.01b

1.53 ± 0.01c

1.38 ± 0.01b

0.87 ± 0.03b

2.76 ± 0.07a

0.82 ± 0.03b

0.94 ± 0.03b

0.85 ± 0.02b

Total

100.00

100.00

100.00

100.00

100.00

100.00

100.00

100

100

100

100

100

100

100

100

100

100

Only major Fatty acid methyl esters were presented; thus they do not add up to 100%. EPA (20:5n-3) were not detected (<0.01%, trace). Each parameter was presented as the mean ± SEM (n = 6). * p < 0.05, ** p < 0.01, significant difference compared to the n-3 Adq group at 3 weeks of age determined by Student’s t-test. Different letters indicate significant difference at p < 0.05 among all dietary groups after 3 weeks of age

SFA saturated fatty acid, MUFA monounsaturated fatty acid, PUFA polyunsaturated fatty acid, N-6 n-6 polyunsaturated fatty acids, N-3 n-3 polyunsaturated fatty acids

The fatty acid composition analysis of brain showed that there were no significant differences in the total saturated fatty acids, monounsaturated fatty acids and PUFAs among all dietary groups, which was consistent with the previous results [6] (Table 3). The ratios of n-6 / n-3 PUFAs of n-3 Adq group (1.05) was significantly lower than that of n-3 Def group (2.88). The ratios of n-6 / n-3 PUFAs in DHA-containing groups exhibited a considerable ecovery after dietary DHA supplementation and reached the normal level by the end of experiment (Table 3). The present results showed that the DHA content of brain was substituted by n-6 PUFAs were likely due to the competition between the n-3 and n-6 families for elongation and desaturation enzymes [22].

Time course of PUFAs alteration in hepatic phospholipids and triglycerides

The liver was the most rapidly recovery of all tissues examined in this study. The initial DHA values in hepatic PL and TG of n-3 deficient mice were significantly decreased by 73.3 and 89.3%, respectively, compared to n-3 Adq group (Fig. 3a and e). The DHA levels in hepatic TG and PL had fully recovered to the normal values when the n-3 Def mice were supplied with the three DHA-containing diets for two days. There were continually marked increase of DHA levels in hepatic PL and TG after DHA supplementation for 4 days. Interestingly, DHA-TG + PC (21.5%) and DHA-TG + α-GPC (20.24%) groups had higher DHA levels than that of DHA-PC group in hepatic PL (17.3%) (Fig. 3a). For liver TG, the DHA concentration of DHA-PC group (2.46%) was also significantly lower than those of DHA-TG + PC (3.49%) and DHA-TG + α-GPC (3.61%) groups (P < 0.05) (Fig. 3e). Previous results found that the ester specific differences were observed only in the livers of normal 10-week-old rats, where the labeled 4C-DHA-PL delivered a 2-fold and 1.5-fold higher accretion of radioactivity compared with 14C-DHA-TG and 14C-DHA-TG + PL, respectively [23]. It was possible that the efficiency of DHA repletion might be influenced by developmental stage of tissue and the initial nutritional status [24]. Compared with the normal adult rats, the mice used in present study were weaning n-3 deficient pups which still in developmental stage and required a mass of n-3 PUFAs to satisfy normal growth. Therefore, we hypothesized that the decreasing DHA accumulation in liver might be beneficial to the availability of DHA for other tissues [11].
Fig. 3
Fig. 3

Variation in DHA (a), DPA (b), AA (c), DTA (d) in hepatic phosphplipids and DHA (e), DPA (f), AA (g), DTA (h) in hepatic thracylglycerols after dietary DHA supplementation from 0 to 4 days. Each parameter is presented as the mean ± SEM (n = 6). ** p < 0.01, significant difference compared to the n-3 Adq group at 3 weeks of age determined by Student’s t-test. Different letters indicate significant difference at p < 0.05 among all dietary groups after 3 weeks of age

Accompanying the loss of DHA, the initial DPA levels in hepatic PL and TG of n-3 Def group were significantly increased by 3.7 and 3.6 folds compared with n-3 Adq group (Fig. 3c and g). After 4 days of DHA supplementation, the DPA content in hepatic PL of DHA-supplemented groups decreased rapidly to nearly 0.5%. And the DPA content in hepetic TG of mice supplied with DHA-PC, DHA-TG + PC and DHA-TG + α-GPC decreased dramatically to 1.11, 0.78 and 0.87%, respectively. In hepatic PL and TG, the AA and DTA levels in n-3 Adq group were significantly lower than those in n-3 Def group.

In hepatic PL, the concentration of AA in DHA-PC, DHA-TG + PC and DHA-TG + α-GPC groups significantly fell from 17 to 8.32%, 7.84%, 7.91%, respectively after 4 days DHA supplementation (Fig. 3c). The AA values in liver TG drastically decreased from 3.26 to 0.45%, 0.61 and 0.42%, respectively after DHA supplementation with DHA-PC, DHA-TG + PC and DHA-TG + α-GPC for 4 days (Fig. 3g). The hepatic DTA pattern for all DHA-supplemented groups was quite similar to that of AA (Fig. 3d and h).

Time course of PUFAs alteration in erythrocyte

The phospholipids have been observed to be cleaved off into lysophospholipids and free fatty acids by phospholipase A2 mediated partial hydrolysis [25]. Previous reports showed that lyso-DHA-PC combined with albumin was the main source of DHA for the erythrocyte using fatty acid labeled with 13C [26]. In erythrocytes, the DHA concentration was significantly lower in n-3 Def group (1.5%) compared to n-3 Adq group (3%), indicating a decrease of 50% at 3 weeks of old (Fig. 4a). Then the DHA value in n-3 Def group rose very slowly to 2.3% over the course of experiment. When the n-3 Def group was supplied with DHA-PC, DHA-TG + PC, DHA-TG + α-GPC during the first week, the DHA content increased rapidly to 4.75, 4.2 and 5.63%, respectively, with a completely recovery compared to n-3 Adq group (4.03%). Then the DHA-TG + PC and DHA-TG + α-GPC groups exhibited a relative increase of DHA level to 8.12 and 8.5% after 2 weeks of supplementation. A faster ascent of DHA from 4.2 to 9.73% was noticed in DHA-PC group. One possible explanation of these results was that a portion of phospholipids might be directly absorbed without phospholipase A2 partial hydrolysis [27]. Ingestion of DHA-PC could increase erythrocyte DHA more effectively compared with DHA-TG [11]. Although the n-3 deficient mice were supplemented with equimolar PC in the three DHA-containing groups, the lyso-DHA-PC concentration in blood of DHA-TG + PC and DHA-TG + α-GPC groups might be less than that in DHA-PC group.
Fig. 4
Fig. 4

Time course curves of DHA (a), DPA (b), AA(c), DTA(d) in erythrocyte after dietary DHA supplementation from 0 to 14 days. Data at various time points are given as mean percent ± SEM (n = 5 mice per time point). Different letters indicate significant difference at p < 0.05 among all dietary groups after 3 weeks of age

Moreover, DHA in the chemical form of lysophosphatidylcholine was uptake to brain by the primary transporter named MFSD2a across the blood-brain barrier [28, 29], and lyso-DHA-PC represented the major part of DHA supplementation in erythrocyte [30]. A previous study indicated that the DHA level of erythrocyte could been taken as a marker of DHA accumulation in brain during the circulating life span [31]. As seen in this paper, we found a similar time course of DHA reversal in erythrocyte and brain, in which the DHA concentration in DHA-PC group was significantly higher than the other DHA-supplemented groups.

The erythrocyte AA content in n-3 Adq pups (6.93%) was much lower than that of n-3 Def pups (13%, Fig. 4c). The DHA-supplemented groups exhibited a considerable decline of AA after DHA supplementation for 1 week, which nearly reached the level of n-3 Adq group (9%). Then the AA values in DHA-PC and DHA-TG + α-GPC groups decreased gradually to 7 and 8.1% while the DHA-TG + PC group rose slightly to 10% after 2 weeks of repletion. For n-3 Adq group, there was a gradual but continuous increment to 9.48% for AA concentration over the experiment. The initial DPA and DTA levels in n-3 Def groups were significantly higher than that of n-3 Adq group and recovered with a time course similar to that of AA after DHA supplementation (Fig. 4b and d). As previous studies, the n-6 PUFAs content of erythrocyte in n-3 deficient mice would be substitited by DHA after dietary DHA supplementation [32].

Time course of PUFAs alteration in testis

Testis fatty acid profiles could be influenced by dietary fat and sensitive to n-3 PUFAs [33]. In mice, high levels of DHA, AA, DPA were observed in membrane phospholipids of round spermatids and mature mouse spermatozoa, which suggested an important role for proper spermatogenesis [34]. In this study, the testis DHA concentration in n-3 Def group reduced by 66.2% (p < 0.05) compared to n-3 Adq group (8.22%) at the weaning day (Fig. 5a). The DHA levels in dietary DHA-containing groups showed an obvious and continuous increment from 0 to 7 days after weaning. Thereafter, the DHA content in DHA-TG + α-GPC group exhibited a relative decrease from 8.33 to 6.62% from 1 to 2 weeks of DHA supplementation, and DHA-PC group remained the DHA level about 9.25%. Interestingly, DHA-TG + PC group exhibited a slight increase from 8.09 to 8.61% in the DHA value during this period, which nearly reach to that of DHA-PC group. The results might be attributed to the rapid growth of mouse testes from 3 to 4 weeks of age, when the testis weight in DHA-PC, DHA-TG + PC and DHA-TG + α-GPC groups significantly rose by 76.3%, 60.4%, 60.2%, respectively, during this period (Fig. 5b). Further analysis showed that the total amounts DHA in testis of DHA-PC, DHA-TG + α-GPC and DHA-TG + PC groups increased by 93.7, 65.6, and 43.8%, respectively, compared with that of n-3 def group, in which the effect of DHA-TG + PC was similar to that of DHA-PC. Similar to brain and retina, mouse contain excessive amount of PUFAs in testis, with particularly high concentration of DHA, which played an important role for sperm development and function [35]. Previous results showed dietary DHA had the positive effects on male fertility [36]. Dietary supplement with DHA could significantly increase DHA content of testes in delta-6 desaturase-null mice, and as a result that the observed impairment in male reproduction was restored [37]. It was meaningful to explore the time course of testis DHA recovery when the weaning n-3 deficient mice were supplemented with different forms of DHA. The results in this study showed that dietary supplementation with DHA-PC was much more effective for testis DHA accretion than DHA-TG + α-GPC during the developing period.
Fig. 5
Fig. 5

Time course curves of DHA, DPA, AA, DTA (a, d, e, f), the weight of testis (b) and total quantities of DHA (c) in testis after dietary DHA supplementation from 0 to 14 days. Different letters indicate significant difference at p < 0.05 among all dietary groups after 3 weeks of age

The initial DPA content of testis in n-3 Adq group (7.98%) was much lower than n-3 Def group (12.33%) (Fig. 5b). The DPA content in DHA-TG + PC and DHA-TG + α-GPC groups displayed a faster decline than that in DHA-PC group within 4 days of DHA supplementation (p < 0.05). Thereafter the DPA levels in DHA-PC and DHA-TG + PC groups decreased slightly to 8.46 and 6.49%, respectively, while DHA-TG + α-GPC group exhibited a rapid decline to 4.26% by the end of DHA supplementation. The time course patterns of AA and DTA in testis were similar to that of DPA as seen in Fig. 5c and d.

Conclusion

The present study investigated the recovery kinetics of tissue DHA after supplementation of DHA-PC and the recombination of DHA-TG with egg PC or α-GPC in weaning n-3 deficient mice induced by maternal dietary deprivation of ALA during pregnancy and lactation. Results showed that dietary DHA supplementation could rapidly recover the DHA concentration of tissues in n-3 deficient mice during the childhood, in which DHA-PC exhibited the optimal efficacy on DHA repletion. Interestingly, the hepatic DHA levels of DHA-TG + PC and DHA-TG + α-GPC groups were significantly higher than that of DHA-PC group after short-term DHA supplementation for 4 days. In addition, DHA-TG + α-GPC exhibited the greater effect on DHA accumulation than DHA-TG + PC in cerebral cortex and erythrocyte, which was similar to DHA-PC. Conversely, DHA-TG + PC was more effective on DHA repletion compared with DHA-TG + α-GPC in testis. Therefore, DHA-PC could not be completely substituted by the recombination of DHA-TG and ordinary PC (not containing any DHA) for DHA supplementation. These findings could pave the way for dietary DHA supplementation in n-3 deficiency conditions especially during childhood, which could provide some references to develop functional foods to support brain development and function.

Abbreviations

AA: 

Arachidonic acid (20:4n6)

ALA: 

a-linolenic acid (18:3n3)

DHA: 

Docosahexaenoic acid (22:6n3)

DPAn-6: 

Docosapentaenoic acid (22:5n6)

DTA: 

Docosatetraenoic acid (22:4n6)

n-3 Adq: 

n-3 adequate

n-3 Def: 

n-3 deficient

PC: 

Phosphatidylcholine

PL: 

Phospholipid

PUFAs: 

Polyunsaturated fatty acids

TG: 

Triglyceride

α-GPC: 

α-Glycerylphosphorylcholine

Declarations

Funding

This work was funded by the National Natural Science Foundation of China (No. 31371757), State Key Program of National Natural Science of China (No. 31330060), National Natural Science Foundation of China-Shandong Joint Fund for Marine Science Research Centers (U1606403) and Fundamental Research Funds for the Central Universities (No. 201762028).

Availability of data and materials

All data generated or analyzed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

FW, YW and TZ conceived and designed the experiments; FW, DW, MW and HC performed the experiments; FW, DW, MW, YW and TZ analyzed the data; FW, DW, TY and CX contributed reagents/materials/analysis tools; FW wrote the paper. All authors have read and approved the final manuscript.

Ethics approval

Animal experiments described in our study were approved by the Ethical Committee of Food Science and Human Health Laboratory of Ocean University of China.

Consent for publication

All authors agree to publish this article in the journal of Lipids in Health and Disease.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
College of Food Science and Engineering, Ocean University of China, No. 5 Yushan Road, Qingdao, 266003, China
(2)
Qingdao National Laboratory for Marine Science and Technology, Laboratory of Marine Drugs & Biological Products, Qingdao, Shandong Province, 266237, China
(3)
Institute of BioPharmaceutical Research, Liaocheng University, Liaocheng, 252059, China
(4)
Laboratory of Nutrition Biochemistry, Department of Applied Biochemistry and Food Science, Saga University, Saga 840-8502, Japan

References

  1. Brand A, Crawford MA, Yavin E. Retailoring docosahexaenoic acid-containing phospholipid species during impaired neurogenesis following omega-3 α-linolenic acid deprivation. J Neurochem. 2010;114:1393–404.PubMedGoogle Scholar
  2. Jr DMJ, Ma K, Bell JM, Rapoport SI. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J Neurochem. 2004;91:1125.View ArticleGoogle Scholar
  3. Neuringer M, Connor WE, Bendich A. Infant vision and retinal function in studies of dietary long-chain polyunsaturated fatty acids: methods, results, and implications. Am J Clin Nutr. 2000;71:256S.PubMedGoogle Scholar
  4. Denomme J, Stark KD, Holub BJ. Directly quantitated dietary (n-3) fatty acid intakes of pregnant Canadian women are lower than current dietary recommendations. J Nutr. 2005;135:206.PubMedGoogle Scholar
  5. Mccann JC, Ames BN. Is docosahexaenoic acid, an n 3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from co. Am J Clin Nutr. 2005;82:281–95.PubMedGoogle Scholar
  6. Moriguchi T, Loewke J, Garrison M, Catalan JN, Salem N Jr. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum. J Lipid Res. 2001;42:419–27.PubMedGoogle Scholar
  7. Schiefermeier M, Yavin E. n-3 Deficient and docosahexaenoic acid-enriched diets during critical periods of the developing prenatal rat brain. J Lipid Res. 2002;43:124.PubMedGoogle Scholar
  8. Hughes D, Bryan J. The assessment of cognitive performance in children: considerations for detecting nutritional influences. Nutr Rev. 2003;61:413.View ArticlePubMedGoogle Scholar
  9. He C, Qu X, Cui L, Wang J, Kang JX. Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc Natl Acad Sci U S A. 2009;106:11370–5.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Ramprasath VR, Eyal I, Zchut S, Jones PJ. Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil. Lipids Health Dis. 2013;12:178.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Liu L, Bartke N, Van DH, Lawrence P, Qin X, Park HG, Kothapalli K, Windust A, Bindels J, Wang Z. Higher efficacy of dietary DHA provided as a phospholipid than as a triglyceride for brain DHA accretion in neonatal piglets. J Lipid Res. 2014;55:531.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Tsushima T, Ohkubo T, Onoyama K, Linder M, Takahashi K. Lysophosphatidylserine form DHA maybe the most effective as substrate for brain DHA accretion. Biocatal Agric Biotechnol. 2014;3:303–9.Google Scholar
  13. Wen M, Ding L, Zhang L, Zhou M, Xu J, Wang J, Wang Y, Xue C. DHA-PC and DHA-PS improved Aβ1-40 induced cognitive deficiency uncoupled with an increase in brain DHA in rats. J Funct Foods. 2016;22:417–30.View ArticleGoogle Scholar
  14. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509.PubMedGoogle Scholar
  15. Ding N, Xue Y, Tang X, Sun ZM, Yanagita T, Xue CH, Wang YM. Short-term effects of different fish oil formulations on tissue absorption of docosahexaenoic acid in mice fed high- and low-fat diets. J Oleo Sci. 2013;62:883.View ArticlePubMedGoogle Scholar
  16. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab. 2010;21:214–22.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Crews F, He J, Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav. 2007;86:189–99.View ArticlePubMedGoogle Scholar
  18. Robertson RC, Oriach CS, Murphy K, Moloney GM, Cryan JF, Dinan TG, Paul RR, Stanton C. Omega-3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav Immun. 2016;59:21.View ArticlePubMedGoogle Scholar
  19. Kitson AP, Metherel AH, Chen CT, Domenichiello AF, Trépanier MO, Berger A, Bazinet RP. Effect of dietary docosahexaenoic acid (DHA) in phospholipids or triglycerides on brain DHA uptake and accretion. J Nutr Biochem. 2016;33:91.View ArticlePubMedGoogle Scholar
  20. Moriguchi T, Harauma A, Salem N Jr. Plasticity of mouse brain docosahexaenoic acid: modulation by diet and age. Lipids. 2013;48:343–55.View ArticlePubMedGoogle Scholar
  21. Bourre JM, Piciotti M. Delta-6 desaturation of alpha-linolenic acid in brain and liver during development and aging in the mouse. Neurosci Lett. 1992;141:65–8.View ArticlePubMedGoogle Scholar
  22. Brenner RR, Peluffo RO, Nervi AM, Tomas MED. Competitive effect of α- and γ-linolenyl-CoA and arachidonyl-CoA in linoleyl-CoA desaturation to γ-linolenyl-CoA. Biochim Biophys Acta, Lipids Lipid Metab. 1969;176:420–2.View ArticleGoogle Scholar
  23. Graf BA, Duchateau GSMJE, Patterson AB, Mitchell ES, Bruggen PV, Koek JH, Melville S, Verkade HJ. Age dependent incorporation of 14 C-DHA into rat brain and body tissues after dosing various 14 C-DHA-esters. Prostaglandins Leukot Essent Fatty Acids. 2010;83:89–96.View ArticlePubMedGoogle Scholar
  24. Harauma A, Salem N Jr, Moriguchi T. Repletion of n-3 fatty acid deficient dams with α-linolenic acid: effects on fetal brain and liver fatty acid composition. Lipids. 2010;45:659.View ArticlePubMedGoogle Scholar
  25. Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6:231.View ArticlePubMedGoogle Scholar
  26. Brossard N, Croset M, Normand S, Pousin J, Lecerf J, Laville M, Tayot JL, Lagarde M. Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells. J Lipid Res. 1997;38:1571.PubMedGoogle Scholar
  27. Bloom B, Kiyasu JY, Reinhardt WO, Chaikoff IL. Absorption of phospholipides; manner of transport from intestinal lumen to lacteals. Am J Phys. 1954;177:84–6.Google Scholar
  28. Nguyen LN, Ma D, Shui G, Wong P, Cazenavegassiot A, Zhang X, Wenk MR, Goh EL, Silver DL. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature. 2014;509:503–6.View ArticlePubMedGoogle Scholar
  29. Zhang TT, Li W, Meng G, Wang P, Liao W. Strategies for transporting nanoparticles across the blood-brain barrier. Biomater Sci. 2016;4:219.View ArticlePubMedGoogle Scholar
  30. Brossard N, Croset M, Lecerf J, Pachiaudi C, Normand S, Chirouze V, Macovschi O, Riou JP, Tayot JL, Lagarde M. Metabolic fate of an oral tracer dose of [13C]docosahexaenoic acid triglycerides in the rat. Am J Physiol. 1996;270:846–54.Google Scholar
  31. Kuratko CN, Jr SN. Biomarkers of DHA status. Prostaglandins Leukot Essent Fatty Acids. 2009;81:111.View ArticlePubMedGoogle Scholar
  32. Levant B, Ozias MK, Carlson SE. Diet (n-3) polyunsaturated fatty acid content and parity affect liver and erythrocyte phospholipid fatty acid composition in female rats. J Nutr. 2007;137:2425–30.PubMedGoogle Scholar
  33. Chanmugam PS, Boudreau MD, Hwang DH. Dietary (n-3) fatty acids alter fatty acid composition and prostaglandin synthesis in rat testis. J Nutr. 1991;121:1173.PubMedGoogle Scholar
  34. Rejraji H, Sion B, Prensier G, Carreras M, Motta C, Frenoux JM, Vericel E, Grizard G, Vernet P, Drevet JR. Lipid remodeling of murine epididymosomes and spermatozoa during epididymal maturation. Biol Reprod. 2006;74:1104.View ArticlePubMedGoogle Scholar
  35. Martínezsoto JC, Landeras J, Gadea J. Spermatozoa and seminal plasma fatty acids as predictors of cryopreservation success. Andrology. 2013;1:365–75.View ArticleGoogle Scholar
  36. Wathes DC, Abayasekara DRE, Aitken RJ. Polyunsaturated fatty acids in male and female Reproduction1. Biol Reprod. 2007;77:190–201.View ArticlePubMedGoogle Scholar
  37. Roquetarivera M, Stroud CK, Haschek WM, Akare SJ, Segre M, Brush RS, Agbaga MP, Anderson RE, Hess RA, Nakamura MT. Docosahexaenoic acid supplementation fully restores fertility and spermatogenesis in male delta-6 desaturase-null mice. J Lipid Res. 2010;51:360–7.View ArticleGoogle Scholar

Copyright

Advertisement